Conjugates of guide RNA-Cas protein complex for genome and epigenome editing
OwnerMinghong ZHONGinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMinghong ZHONGinventor
Estimating the term…
Provided herein are compositions of conjugates of a guide RNA(s)-CRISPR Cas protein (RNP) complex. The conjugate comprises a guide RNA(s)-CRISPR Cas protein (RNP) complex and one or more molecules selected from PEG, non-PEG polymers, ligands for cellular receptors, lipids, oligonucleotides, polysaccharides and peptides and chemically linked to the Cas protein and/or guide RNA(s). Also provided a guide RNA-DNA template conjugate comprises a DNA template with 5-methylcytosines at specific positions for epigenome editing by DNA methylation at a single nucleotide resolution level. The conjugates are delivered to targeted cells as RNP complexes, or formed in targeted cells from guide RNA conjugates and an mRNA or a viral vector encoding a Cas protein, or formed in targeted cells from a crRNA conjugate(s) and a viral vector encoding both a Cas protein and a tracrRNA. Also provided are preparation methods and uses of these conjugates.
A conjugate of CRISPR-Cas protein-guide RNA(s) complex, comprising
Pharmaceutical agents comprising conjugates of a CRISPR-Cas protein-guide RNA complex.
A method of gene editing with conjugates of a CRISPR-Cas protein guide RNA complex, comprising the following steps:
Dependencies are inferred from the claim text.